Haemonetics | HAE - Operating Expenses


Haemonetics reported $145.34M in Operating Expenses for its fiscal quarter ending in June of 2026.





Operating Expenses Change Date
Baxter International USD 2.68B 3.36B Jun/2026
Becton, Dickinson and Co. USD 24.42B 283M Jun/2026
Boston Scientific USD 4.2B 49M Jun/2026
Cerus USD 34.78M 2.98M Dec/2024
Cooper Companies USD 844.2M 268.3M Jun/2026
Fresenius EUR 5.23B 9M Jun/2026
Fresenius Medical Care EUR 4.32B 20.7M Jun/2026
Globus Medical USD 835.58M 239.73M Jun/2026
Haemonetics USD 145.34M 148.66M Jun/2026
ICU Medical USD 491.25M 8.59M Jun/2026
Intuitive Surgical USD 2B 86.5M Sep/2026
Medtronic USD 7.92B 203M Jun/2026
Merit Medical Systems USD 358.44M 20.72M Jun/2026
Neogen USD 224.6M 2.4M Jun/2026
OraSure Technologies USD 40.35M 2.45M Dec/2025
Plus Therapeutics USD 8.15M 1.04M Mar/2026
Quidel USD 646.2M 1.21B Jun/2026
ResMed USD 1.01B 83.57M Jun/2026
STAAR Surgical USD 83.43M 7.32M Jun/2026
Steris USD 1.21B 62.8M Jun/2026
Stryker USD 4.8B 118M Jun/2026
Teleflex USD 2.9B 179.9M Jun/2026
Terumo JPY 222.33B 46.54B Jun/2026
Thermo Fisher Scientific USD 9.68B 134M Sep/2026
US Physical Therapy USD 192.11M 6.23M Jun/2026
Zimmer Biomet Holdings USD 1.83B 140.7M Jun/2026